Keywords
chagas disease
cardiovascular trypanosomiasis
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze studies and evidence on Chagas cardiomyopathy and its consequences. Bibliographic review: The epidemiology of Chagas disease has changed, surpassing the limits of endemic territories, becoming a global health issue today. Chagas cardiomyopathy affects about one-third of individuals with Chagas disease, characterized by its inflammatory repercussions in the heart tissue, causing functional and anatomical changes in this organ. In the chronic phase of the disease, Chagas cardiomyopathy can have different clinical presentations, from asymptomatic patients to those with electrical conduction abnormalities, heart failure and thrombus formation. In addition, sudden cardiac death is the main cause of death in patients with Chagas disease, and may even be the first manifestation of the pathology. Final considerations: The existence of clinical and complementary findings must be in the line of reasoning of professionals for the suspicion of Chagas cardiomyopathy. Thus, it is evident that the early diagnosis favors the pathology not to culminate in terminal stages and consequences are reduced. Furthermore, there is a shortage in the current literature on the subject that needs to be revised and reversed.
References
BONNEY KM, et al. Pathology and Pathogenesis of Chagas Heart Disease. Annu Rev Pathol, 2019; 14: 421-447.
BENCK L, et al. Diagnosis and Management of Chagas Cardiomyopathy in the United States. Curr Cardiol Rep, 2018; 20(12): 131.
CHADALAWADA S, et al. Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis. ESC Heart Fail, 2021; 8(6): 5466-5481.
CHAVES AT, et al. Myocardial fibrosis in chagas disease and molecules related to fibrosis. Parasite Immunol, 2019; 41(10): e12663.
COSTA HS, et al. Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges. Rev Soc Bras Med Trop, 2020; 53: e20200100.
ECHAVARRÍA NG, et al. Chagas Disease: Chronic Chagas Cardiomyopathy. Curr Probl Cardiol, 2021; 46(3): 100507.
EDWARDS MS, MONTGOMERY SP. Chagas disease: progress toward implementation of pregnancy-based screening. Curr Opin Infect Dis, 2021; 34(5): 538-545.
GONZÁLEZ-ZAMBRANO, et al. Prevalence of Chagas heart disease in dilated cardiomyopathy. Arch Cardiol Mex, 2020; 91(1): 50-57.
KEEGAN R, et al. Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature. Arrhythm Electrophysiol Rev, 2020; 9(4): 175-181.
KOH CC, et al. Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease. Pathogens, 2023; 12(2): 171.
LIDANI KCF, et al. Chagas Disease: From Discovery to a Worldwide Health Problem. Front Public Health, 2019; 7: 166.
MARTINEZ F, et al. Chagas Disease and Heart Failure: An Expanding Issue Worldwide. Eur Cardiol, 2019; 14(2): 82-88.
MEDINA-RINCÓN GJ, et al. Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review. Pathogens, 2021; 10(11): 1493.
MONTALVO-OCOTOXTLE IG, et al. Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure. J Clin Med, 2022; 11(24): 7262.
NUNES MCP, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation, 2018; 138(12): e169-e209.
PINO-MARÍN, et al. Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death. Pathogens, 2021; 10(5): 505.
RADISIC MV, REPETTO SA. American trypanosomiasis (Chagas disease) in solid organ transplantation. Transpl Infect Dis, 2020; 22(6): e13429.
SANTOS É, FALCÃO LM. Chagas cardiomyopathy and heart failure: From epidemiology to treatment. Rev Port Cardiol (Engl Ed), 2020; 39(5): 279-289.
SIMÕES VAL, et al. Cost-effectiveness of an exercise-based cardiovascular rehabilitation program in patients with chronic Chagas cardiomyopathy in Brazil: An analysis from the PEACH study. Trop Med Int Health, 2022; 27(7) :630-638.
SUÁREZ C, et al. Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas. Res Rep Trop Med, 2022; 13: 25-40.
SIMÕES MV, et al. Cardiomiopatia da Doença de Chagas. International Journal of Cardiovascular Sciences, 2018; 31(2): 173-189.
VELASCO A, MORILLO CA. Chagas heart disease: A contemporary review. J Nucl Cardiol, 2020; 27(2): 445-451.
VIEIRA JL, et al. Chagas Cardiomyopathy in Latin America Review. Curr Cardiol Rep, 2019; 21(2): 8.